Technology’s Role in Addressing Potential Drug Safety Risks
This White Paper is part of DIA’s White Paper Library
While not all safety data sources are amenable to automation (and human review will always remain a critical component), artificial intelligence (AI) and natural language processing have proven to be effective, when properly applied to the right scenario, in drug safety monitoring. This paper discusses key learnings in applying an AI-enabled safety risk detection system to many different scenarios across multiple therapeutic areas and offers recommendations for developing a robust drug safety monitoring program to better comply with regulatory requirements.
Download Now!
INTERESTED IN PUBLISHING?
For more information on publishing your White Paper with DIA, including schedule and pricing, please contact Heej Ko at [email protected].
For more information on publishing your White Paper with DIA, including schedule and pricing, please contact Heej Ko at [email protected].